Table 4.
Hazard Ratios (HR) of Colorectal Cancer Associated with Laxative Use, by Subsite
Colon Cancer
|
Rectal Cancer
|
||||||
---|---|---|---|---|---|---|---|
Case/Cohorta | HRb | (95% CI) | Case/Cohorta | HRb | (95% CI) | P for difference | |
|
|
||||||
Non-Fiber Laxative Use (10 year) | |||||||
<1x/year | 232/49,323 | 1.00 | Ref | 93/49,706 | 1.00 | Ref | 0.35 |
1–4x/year | 44/4,719 | 1.60 | (1.08–2.38) | 6/4,753 | 0.98 | (0.39–2.49) | |
≥5x/year | 18/2,542 | 1.63 | (0.89–2.98) | 3/2,565 | 0.80 | (0.20–3.09) | |
Ptrend | 0.002 | 0.78 | |||||
Fiber Laxative Use (10 year) | |||||||
Non-User | 274/52,039 | 1.00 | Ref | 99/52,039 | 1.00 | Ref | 0.97 |
Low (<4 days/week or <4 yrs) | 31/5,049 | 1.22 | (0.83–1.83) | 8/5,049 | 0.91 | (0.39–2.16) | |
High (4+ days/week for 4+ yrs) | 6/2,681 | 0.40 | (0.17–0.99) | 2/2,681 | 0.57 | (0.14–2.36) | |
Ptrend | 0.26 | 0.46 |
n: # after fter adjustment for all covariates (listed below)
Adjusted for: age, sex, race/ethnicity,education, smoking, BMI, physical activity, family history of CRC, colonoscopy/sigmoidoscopy screening, history of polyp removal, aspirin use, NSAID use, hormone replacement therapy use (among women), caloric intake, fiber, fruit & vegetable intake, red/processed meat intake, alcohol consumption, calcium, non-fiber laxative use, fiber laxative use, bowel movement frequency and constipation